ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Field of Research : Cardiology (incl. Cardiovascular Diseases)
Research Topic : ALZHEIMER'S DISEASE
Clear All
Filter by Field of Research
Cardiology (incl. Cardiovascular Diseases) (219)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (219)
Filter by Status
Closed (219)
Filter by Scheme
NHMRC Project Grants (57)
Project Grants (55)
Postgraduate Scholarships (28)
Early Career Fellowships (17)
NHMRC Postgraduate Scholarships (16)
Career Development Fellowships (10)
Research Fellowships (9)
NHMRC Research Fellowships (4)
Partnerships (4)
Practitioner Fellowships (4)
Program Grants (4)
Centres of Research Excellence (3)
Development Grants (2)
NHMRC Strategic Awards (2)
Targeted Calls (2)
Centre for Research Excellence (1)
NHMRC Development Grants (1)
Filter by Country
Australia (18)
Filter by Australian State/Territory
VIC (10)
WA (8)
NSW (5)
QLD (2)
SA (2)
  • Researchers (0)
  • Funded Activities (219)
  • Organisations (19)
  • Funded Activity

    Biochemistry And Functional Significance Of Glycosylation Of Apolipoprotein E

    Funder
    National Health and Medical Research Council
    Funding Amount
    $485,000.00
    Summary
    Apolipoprotein E (apoE) is an important molecule which affects our risk of atherosclerosis- coronary disease and of Alzheimer's disease. We know that apoE's functions are very much affected by its structure. One aspect of tis structure which has been neglected is the attachment of sugar molecules . These are very likely to regulate how apoE interacts with other molecules, with cells, and is metabolised in the body and will be investigated in this project.
    More information
    Funded Activity

    Long-term Surgical And Socioeconomic Outcomes Following Aortopulmonary Septal Defect Repair In Children

    Funder
    National Health and Medical Research Council
    Funding Amount
    $89,197.00
    Summary
    About 2% of heart defects are due to communication between the 2 main arteries exiting the heart (truncus arteriosus and aortopulmonary window). If untreated, up to 30% of children die in the first year of life. With surgery many patients are now surviving into adulthood. The long-term outcomes are unknown. This study will review all patients with this defect across Australian and New Zealand. Results from this study will allow us to best manage these patients in the short and long-term.
    More information
    Funded Activity

    The Access Project - Assessment Of Coronary Artery Disease Using CT Effectively For Stable Symptoms

    Funder
    National Health and Medical Research Council
    Funding Amount
    $754,369.00
    Summary
    Invasive Coronary Angiography (ICA) provides x-ray visualisation of coronary disease (CAD) that is essential for coronary surgery/balloon angioplasty. However many patients undergo this procedure without requiring these therapies despite the associated severe complications. The ACCESS Project screens patients scheduled for ICA, identifying those unlikely to have CAD and referring them for non-invasive CT angiography. This strategy reduces procedure complications and result in major cost savings.
    More information
    Funded Activity

    Evaluating Coronary Stents Using High-resolution Optical Coherence Tomography Imaging In Patients With Coronary Artery Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $217,274.00
    Summary
    A stent is a device made of metal that is placed inside an artery to prop it. Recently, the applicant introduced into Australia a novel technology to examine these stents once inside the body. This information may help make stents safer for patients
    More information
    Funded Activity

    Redefining The Role Of Macrophages In Atherosclerosis: Macrophage Subset Role In Plaque Stability

    Funder
    National Health and Medical Research Council
    Funding Amount
    $509,190.00
    Summary
    Vascular disease is a major cause of death and disability through events such as heart attack and stroke. A blood cell, called a macrophage, plays a major detrimental role. However, we have identified the presence of an alternate form of this cell in vascular disease that we propose may play an opposing, beneficial role. We will thus re-define the role of the macrophage in vascular disease and predict that we will be able to demonstrate an alternate healing role. This will provide a new therapeu .... Vascular disease is a major cause of death and disability through events such as heart attack and stroke. A blood cell, called a macrophage, plays a major detrimental role. However, we have identified the presence of an alternate form of this cell in vascular disease that we propose may play an opposing, beneficial role. We will thus re-define the role of the macrophage in vascular disease and predict that we will be able to demonstrate an alternate healing role. This will provide a new therapeutic approach for treatment of atherosclerosis.
    Read more Read less
    More information
    Funded Activity

    Practitioner Fellowship - Grant ID:458505

    Funder
    National Health and Medical Research Council
    Funding Amount
    $420,541.00
    Summary
    I am a vascular surgeon studying novel genetic and acquired markers of increasing aortic diameter and other manifestations of cardiovascular disease
    More information
    Funded Activity

    Y Chromosome Mechanisms In Coronary Artery Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $369,076.00
    Summary
    The Y chromosome determines sex in men and until recently was not thought to contribute to heart disease. We previously found a specific type of Y chromosome that does contribute to heart disease. In the current project we plan to find the exact gene and mechanism in the search as a therapeutic target.
    More information
    Funded Activity

    A Dual Antigen Synthetic Peptide Subunit Vaccine Approach To Prevent Streptococcal Associated Cardiovascular Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $604,017.00
    Summary
    Infection with streptococcus is responsible for causing more than 500,000 deaths each year, the majority of which are due to rheumatic fever and rheumatic heart disease, which contributes to cardiovascular disease. Our research is aimed at the development of a vaccine to prevent heart disease and involves targeting multiple molecules present on the bacterial surface. We will use a novel vaccine delivery system developed in the laboratory, which will enable the vaccine to be delivered nasally.
    More information
    Funded Activity

    Central Blood Pressure And Cardiovascular Risk In Children Within The General Population And After Repair Of Congenital Heart Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $431,000.00
    Summary
    With an exceptional research standing internationally, and as the leader of a Cardiovascular Bioengineering team, I am developing a new method for assessing central blood pressure in children that will provide better information about early risk of cardiovascular disease than arm blood pressure. This will be applied (1) in a large health study of Australian children and (2) to identify risks and causes of adult-type cardiovascular disease in children with repaired congenital heart disease.
    More information
    Funded Activity

    Coronary Artery Calcium Score: Use To Guide Management Of Hereditary Coronary Artery Disease (CAUGHT-CAD)

    Funder
    National Health and Medical Research Council
    Funding Amount
    $2,762,082.00
    Summary
    Lifetime risk of coronary artery disease (CAD) is doubled in families with premature CAD. This study will be the first randomized controlled trial of the use of coronary artery calcium scoring (CCS) in relatives of patients with premature CAD, in which treatment will be initiated based on CCS. At three years, the effectiveness of intervention will be assessed on change in plaque volume at CT coronary angiography. The results inform the guidelines regarding evaluation of families with CAD.
    More information

    Showing 1-10 of 219 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback